What's in Keith D Lindor, M.D.'s pipeline?

Keith D Lindor, M.D. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Keith D Lindor, M.D.'s portfolio?

Top competitors by shared drug class: Air Force Military Medical University, China, Elijah W. Stommel, Hadassah Medical Organization, McMaster University, The University of Texas at Arlington.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/keith-d-lindor-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Keith D Lindor, M.D. — Portfolio Competitive Intelligence Brief

Keith D Lindor, M.D. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
L-alanine	L-alanine	marketed	Amino acid supplement		Nutrition / Metabolic support

Therapeutic area mix

Nutrition / Metabolic support · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Air Force Military Medical University, China · 1 shared drug class
Elijah W. Stommel · 1 shared drug class
Hadassah Medical Organization · 1 shared drug class
McMaster University · 1 shared drug class
The University of Texas at Arlington · 1 shared drug class
Ukrainian Medical Stomatological Academy · 1 shared drug class
University Hospital, Strasbourg, France · 1 shared drug class
University of Colorado, Denver · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Keith D Lindor, M.D.:

Cite this brief

Drug Landscape (2026). Keith D Lindor, M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/keith-d-lindor-m-d. Accessed 2026-05-16.